Cortactin (CTTN) Peptide
CTTN
Reactivité: Humain
Hôte: Synthetic
BP, WB, IHC
-
- Antigène Tous les produits Cortactin (CTTN)
- Cortactin (CTTN)
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-CTTN antibody (Catalog #: ARP52067_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- Cortactin (CTTN)
- Synonymes
- EMS1 Peptide, 1110020L01Rik Peptide, Ems1 Peptide, Cttnb Peptide, CG3637 Peptide, Dmel\CG3637 Peptide, cortactin Peptide, cttn Peptide, CTTN1 Peptide, P85.25 Peptide, Cttn Peptide, ems1 Peptide, CTTN Peptide, cortactin Peptide, CG3637 gene product from transcript CG3637-RD Peptide, cortactin S homeolog Peptide, cortactin L homeolog Peptide, src substrate cortactin Peptide, Src substrate cortactin Peptide, CTTN Peptide, Cttn Peptide, Cortactin Peptide, cttn.S Peptide, cttn.L Peptide, cttn Peptide, CpipJ_CPIJ006351 Peptide, Bm1_57220 Peptide, LOC100533277 Peptide
- Sujet
-
CTTN is overexpressed in breast cancer and squamous cell carcinomas of the head and neck. CTTN is localized in the cytoplasm and in areas of the cell-substratum contacts. It has two roles: (1) regulating the interactions between components of adherens-type junctions and (2) organizing the cytoskeleton and cell adhesion structures of epithelia and carcinoma cells. During apoptosis, CTTN is degraded in a caspase-dependent manner. The aberrant regulation of t CTTN contributes to tumor cell invasion and metastasis.This gene is overexpressed in breast cancer and squamous cell carcinomas of the head and neck. The encoded protein is localized in the cytoplasm and in areas of the cell-substratum contacts. This gene has two roles: (1) regulating the interactions between components of adherens-type junctions and (2) organizing the cytoskeleton and cell adhesion structures of epithelia and carcinoma cells. During apoptosis, the encoded protein is degraded in a caspase-dependent manner. The aberrant regulation of this gene contributes to tumor cell invasion and metastasis. Two splice variants that encode different isoforms have been identified for this gene.
Alias Symbols: EMS1, FLJ34459
Protein Interaction Partner: ARHGAP8,ACTA1,ACTR3,ANKZF1,CHD3,CTNND1,CTNND2,CTTN,CTTNBP2,DNM1,DNM2,FER,FGD1,GRB2,HAX1,HIP1R,KCNA2,MET,MYLK,NCF1,SDC3,SHANK2,SRC,SYK,TJP1,WIPF1,ACTR2,ACTR3,ARHGAP17,ARPC2,ARPC3,ARPC4,ASAP1,CASP3,CHD3,CRB2,CTNND1,FER,KCNA2,MYLK,PXN,SDC3,SHANK2,SYK,WASL,WIPF1
Protein Size: 550 - Poids moléculaire
- 61 kDa
- ID gène
- 2017
- NCBI Accession
- NM_005231, NP_005222
- UniProt
- Q8N707
-
Vous êtes ici:
